| pubmed-article:10210643 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10210643 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:10210643 | lifeskim:mentions | umls-concept:C0346647 | lld:lifeskim |
| pubmed-article:10210643 | lifeskim:mentions | umls-concept:C0162638 | lld:lifeskim |
| pubmed-article:10210643 | lifeskim:mentions | umls-concept:C0334227 | lld:lifeskim |
| pubmed-article:10210643 | lifeskim:mentions | umls-concept:C0036077 | lld:lifeskim |
| pubmed-article:10210643 | lifeskim:mentions | umls-concept:C1523116 | lld:lifeskim |
| pubmed-article:10210643 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
| pubmed-article:10210643 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:10210643 | pubmed:dateCreated | 1999-5-13 | lld:pubmed |
| pubmed-article:10210643 | pubmed:abstractText | Tumor necrosis factor (TNF-alpha)-induced apoptosis is limited by its coactivation of nuclear factor kappa B (NF-kappaB)-dependent anti-apoptotic genes. Sodium salicylate (NaSal) inhibits NF-kappaB activation by limiting phosphorylation and degradation of its bound inhibitor protein, IkappaB-alpha. We examined whether NaSal enhances TNF-alpha-induced apoptosis in cultured human pancreatic cancer cell lines. | lld:pubmed |
| pubmed-article:10210643 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10210643 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10210643 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10210643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10210643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10210643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10210643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10210643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10210643 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10210643 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10210643 | pubmed:month | May | lld:pubmed |
| pubmed-article:10210643 | pubmed:issn | 0022-4804 | lld:pubmed |
| pubmed-article:10210643 | pubmed:author | pubmed-author:McEwanA DAD | lld:pubmed |
| pubmed-article:10210643 | pubmed:author | pubmed-author:CalleryM PMP | lld:pubmed |
| pubmed-article:10210643 | pubmed:author | pubmed-author:VittimbergaF... | lld:pubmed |
| pubmed-article:10210643 | pubmed:author | pubmed-author:PeruginiR ARA | lld:pubmed |
| pubmed-article:10210643 | pubmed:author | pubmed-author:CarriganR CRC | lld:pubmed |
| pubmed-article:10210643 | pubmed:copyrightInfo | Copyright 1999 Academic Press. | lld:pubmed |
| pubmed-article:10210643 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10210643 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:10210643 | pubmed:volume | 83 | lld:pubmed |
| pubmed-article:10210643 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10210643 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10210643 | pubmed:pagination | 56-61 | lld:pubmed |
| pubmed-article:10210643 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:meshHeading | pubmed-meshheading:10210643... | lld:pubmed |
| pubmed-article:10210643 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10210643 | pubmed:articleTitle | Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. | lld:pubmed |
| pubmed-article:10210643 | pubmed:affiliation | Department of Surgery, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. | lld:pubmed |
| pubmed-article:10210643 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10210643 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10210643 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10210643 | lld:pubmed |
